[C.S.] Taiwan's largest kalanchoe specialty retail chain has been listed in the US and announced its successful acquisition of Direct-to-Consumer (DTC) certification for electronic trading settleme...

Cordyceps Sunshine [CS Group] is a leading expert in Taiwan's precious fungi. Since 2020, it has acquired multiple patented cultivation technologies for Taiwan's most representative medicinal fungus, Antrodia camphoratus . The company has established successful mass production of Antrodia camphoratus cultivation centers in Yilan, Taiwan, and Guangdong, China.

We are pleased to announce that the Company has received DTC eligibility from the Depository Trust Company ("DTC") for its shares in the OTC market, and its common stock can now be electronically cleared and settled in the United States through the Depository Trust Company ("DTC").

DTC is a subsidiary of the Depository Trust & Clearing Corporation, which manages the electronic clearing and settlement of publicly traded securities. Securities eligible for electronic clearing and settlement through DTC are considered "DTC-eligible." This method of electronically clearing securities expedites the receipt of stock and cash, speeding up the settlement process for investors and brokers, and enabling stocks to be traded across a wider selection of brokerage firms by complying with their requirements.

CS Group defines the Antrodia cinnamomea industry

Taiwan's unique medicinal fungus, Antrodia cinnamomea, boasts edible benefits surpassing those of Ganoderma lucidum and Cordyceps sinensis. However, Antrodia cinnamomea grows only on fallen trees of the Taiwanese forest species Cinnamomum kanehirae Hayata. Consequently, these trees are being cut down en masse for cultivation, posing a threat to their survival.

CS Group has pooled industry resources and invested hundreds of millions of dollars to select ceramic materials that mimic the structural density of the Antrodia cinnamomea tree. They then infuse it with potent Antrodia cinnamomea strains and nutrients. The resulting Antrodia cinnamomea achieves both an appearance and active ingredients that are identical to those of its wild counterparts, effectively overcoming the core issue of the Antrodia cinnamomea tree shortage that has plagued the industry for years.

[Building Taiwan's largest Antrodia cinnamomea chain store]

CS Group is the first major conglomerate to establish Taiwan's largest chain of Antrodia cinnamomea stores. Starting in 2023, the company will establish directly-operated chain stores under its Tiancao.Gasar Antrodia cinnamomea specialty brand in popular areas such as Dihua Street in Taipei, the East District shopping district in Taipei, and Sanfeng Middle Street in Kaohsiung. The stores offer a diverse selection of Antrodia cinnamomea health supplements and specialty Antrodia cinnamomea delicacies, and will also feature outdoor advertising at numerous popular locations in Taipei to enhance the brand's image. The key to CS Group's successful store expansion lies in its mastery of the mass production technology for cultivating Antrodia cinnamomea fruiting bodies, which effectively controls costs.

(Top) Taipei East District Store (Left) Taipei Dihua Street Store (Right) East District Store Interior

【Officially entering the world's largest Chinese herbal medicine market】

CS Group's Antrodia cinnamomea cultivation technology has been granted patents in Taiwan, China, and Japan for "Antrodia cinnamomea cultivation methods and porous culture carriers," with patents pending in the United States. The Chinese government also designated our Antrodia cinnamomea cultivation technology as the sole industry standard in its 2022 "Group Standard for Antrodia cinnamomea Production Technology Specifications." CS Group is currently collaborating with Baoquan Agricultural Biotechnology, its exclusive distributor in Greater China, to successfully establish its first Antrodia cinnamomea cultivation and production center in Guangzhou, China, officially entering the world's largest Chinese herbal medicine market.

CS Group's revenue is poised for exponential growth.

CS Group is the first US-listed company primarily focused on Antrodia cinnamomea assets, having successfully passed US Direct-to-Consumer (DTC) approval. With stable revenue generation expected in 2023, the company will begin expanding its Antrodia cinnamomea industry presence in Greater China in 2024. The overall benefits will gradually materialize, ushering in a golden period of exponential revenue growth for the Group, which will contribute to future stock price appreciation. CS Group is fully regulated by US securities laws. Entering the US capital market will further enhance its brand awareness and competitiveness, realizing the amplified value of industry-integrated capital and bringing a better life to people around the world.

Central News Agency News Report: https://reurl.cc/NQv4rk

Taiwan Yahoo News Report: https://reurl.cc/6vo7EO

Taiwan Economic Daily report: https://reurl.cc/5vj4OR

China Medical Network report: https://reurl.cc/9ve7vv